HOFFMANN EITLE English

Diese Seite ist nicht auf Deutsch verfügbar. Hier gelangen Sie zur deutschen Homepage.

This page isn’t available in English. Here, you’ll get to the English homepage.

このページには日本語版がございません。

Esta página no está disponible en español - Aquí podrá acceder a la página web en español.

Questa pagina non è disponibile in italiano. Qui si accede alla homepage in italiano.

Cette page n’est pas disponible en français. Ce lien vous conduira à la page d'accueil en français.

해당 페이지는 한국어가 지원되지 않습니다. 이 곳을 클릭하시면 한국어 버전 홈페이지로 이동하게 됩니다.

Author(s): D. Schüssler-Langeheine

Dr. Dirk Schüssler-Langeheine, attorney-at-law and partner in HOFFMANN EITLE's Patent Litigation & Licensing group, participated in an expert forum on questions of pharma and biotech litigation. He has been supported by fellow partners Dr. Leo Polz, patent attorney in HOFFMANN EITLE's biotech team, and Dr. Niels Hölder, attorney-at-law. The discussion has been published in the current issue of Corporate Disputes, a quarterly e-magazine dedicated to the latest developments in corporate and commercial disputes.

The full text of the discussion is available for free download below.
Pharma and Biotech Patent Litigation (Corporate Disputes, Apr-Jun 2014) (PDF / 1,1 MB)